2 Organisations
Direct Investments & Incentives
Government direct investments, R&D tax credits, and incentive programmes for psychedelic medicine development.
- Organisations
- 2
- Countries
- 1
By country
All Organisations
Defense Advanced Research Projects Agency (DARPA)
US defense research funder with psychedelic-informed neuropsychiatric R&D (Focused Pharma).
View Profile
United States
US Advanced Research Projects Agency for Health (ARPA-H)
Other
ARPA-H is the US federal agency for high-risk, high-reward biomedical research. Launched the EVIDENT initiative in 2025 (total $139.4M, ≥$50M earmarked for psychedelic research for serious mental illness) to validate and innovate behavioral-health therapeutics including psilocybin and related compounds.
View Profile